Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed El-Tanani

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
International Journal of Oncology|November 8, 2006
Identification of apolipoprotein D as a novel inhibitor of osteopontin-induced neoplastic transformationDachuan Jin, Mohamed El-Tanani, Frederick Charles Campbell
Frontiers in Clinical Diabetes and Healthcare|November 19, 2024
In-silico modelling of insulin secretion and pancreatic beta-cell function for clinical applications: is it worth the effort?Andrea Tura, Christian Göbl, Mohamed El-Tanani, et al.
Biomedicines|February 26, 2025
Obesity: Recent Advances and Future PerspectivesMiodrag Janić, Andrej Janež, Mohamed El-Tanani, et al.
Journal of Diabetes and Its Complications|July 17, 2024
Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity?Dimitrios Patoulias, Paschalis Karakasis, Mohamed El-Tanani, et al.
Science Progress|November 5, 2024
Pimozide-loaded nanostructured lipid carriers: Repurposing strategy against lung cancerWafa' A Al-Haj, Hamdi Nsairat, Mohamed El-Tanani
Cancers|March 18, 2016
Mechanisms of Nuclear Export in Cancer and Resistance to ChemotherapyMohamed El-Tanani, El-Habib Dakir, Bethany Raynor, et al.
Drug Development and Industrial Pharmacy|November 11, 2024
<i>In vitro</i> evaluation of lipidic nanocarriers for mebendazole delivery to improve anticancer activityM Amin Tamma, Hamdi Nsairat, Mohamed El-Tanani, et al.
Pharmaceutics|December 23, 2023
Inhaled Medicines for Targeting Non-Small Cell Lung CancerArwa Omar Al Khatib, Mohamed El-Tanani, Hisham Al-Obaidi
Pharmaceutics|September 28, 2024
Correction: Al Khatib et al. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. <i>Pharmaceutics</i> 2024, <i>15</i>, 2777Arwa Omar Al Khatib, Mohamed El-Tanani, Hisham Al-Obaidi
Pharmaceutical Research|December 19, 2018
Anti-Invasive and Anti-Proliferative Effects of shRNA-Loaded Poly(Lactide-Co-Glycolide) Nanoparticles Following RAN Silencing in MDA-MB231 Breast Cancer CellsAnkur Sharma, Paul McCarron, Kyle Matchett, et al.
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Oncology|November 8, 2006
Identification of apolipoprotein D as a novel inhibitor of osteopontin-induced neoplastic transformationDachuan Jin, Mohamed El-Tanani, Frederick Charles Campbell
Frontiers in Clinical Diabetes and Healthcare|November 19, 2024
In-silico modelling of insulin secretion and pancreatic beta-cell function for clinical applications: is it worth the effort?Andrea Tura, Christian Göbl, Mohamed El-Tanani, et al.
Biomedicines|February 26, 2025
Obesity: Recent Advances and Future PerspectivesMiodrag Janić, Andrej Janež, Mohamed El-Tanani, et al.
Journal of Diabetes and Its Complications|July 17, 2024
Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity?Dimitrios Patoulias, Paschalis Karakasis, Mohamed El-Tanani, et al.
Science Progress|November 5, 2024
Pimozide-loaded nanostructured lipid carriers: Repurposing strategy against lung cancerWafa' A Al-Haj, Hamdi Nsairat, Mohamed El-Tanani
Cancers|March 18, 2016
Mechanisms of Nuclear Export in Cancer and Resistance to ChemotherapyMohamed El-Tanani, El-Habib Dakir, Bethany Raynor, et al.
Drug Development and Industrial Pharmacy|November 11, 2024
<i>In vitro</i> evaluation of lipidic nanocarriers for mebendazole delivery to improve anticancer activityM Amin Tamma, Hamdi Nsairat, Mohamed El-Tanani, et al.
Pharmaceutics|December 23, 2023
Inhaled Medicines for Targeting Non-Small Cell Lung CancerArwa Omar Al Khatib, Mohamed El-Tanani, Hisham Al-Obaidi
Pharmaceutics|September 28, 2024
Correction: Al Khatib et al. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. <i>Pharmaceutics</i> 2024, <i>15</i>, 2777Arwa Omar Al Khatib, Mohamed El-Tanani, Hisham Al-Obaidi
Pharmaceutical Research|December 19, 2018
Anti-Invasive and Anti-Proliferative Effects of shRNA-Loaded Poly(Lactide-Co-Glycolide) Nanoparticles Following RAN Silencing in MDA-MB231 Breast Cancer CellsAnkur Sharma, Paul McCarron, Kyle Matchett, et al.
Pageof 19